Previous fludarabine treatment is a strong predictor for long-term cytopenia in non-Hodgkin lymphoma (NHL) patients treated with Y-90 ibritumomab tiuxetan

H. Bentzen, B. Bach, H. Larsen, S. Pulczynski, N. Peterslund, Ilse Christiansen, M. Frederiksen, F. D'Amore

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

OriginalsprogEngelsk
TidsskriftAnnals of Oncology
Sider (fra-til)245
Antal sider1
ISSN0923-7534
StatusUdgivet - 2008
Udgivet eksterntJa
BegivenhedPrevious fludarabine treatment is a strong predictor for long-term cytopenia in non-Hodgkin lymphoma (NHL) patients treated with Y-90 ibritumomab tiuxetan -
Varighed: 17 dec. 201017 dec. 2010

Konference

KonferencePrevious fludarabine treatment is a strong predictor for long-term cytopenia in non-Hodgkin lymphoma (NHL) patients treated with Y-90 ibritumomab tiuxetan
Periode17/12/201017/12/2010

Bibliografisk note

Udgivelsesdato: 2008 Volumne: 19

Citationsformater